 |
|
|
| |
A Phase 1 Study Evaluating Anti-PD-1 Treatment
With or Without GS-4774 in HBeAg Negative
Chronic Hepatitis B Patients
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Edward J. Gane* 1, Anuj Gaggar 2, Anh Hoa Nguyen 2, G Mani Subramanian 2,
John G. McHutchison 2, Daniel Verdon 3, Christian Schwabe 1, Rod Dunbar3
1Auckland Clinical Studies, Auckland, New Zealand, 2Gilead Sciences, Inc., Foster City, California, USA,
3University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
